Trials / Completed
CompletedNCT03655041
24-Wk β-Alanine Ingestion on Muscle Taurine and Clinical Blood Parameters in Healthy Males
24-Weeks of β-Alanine Ingestion on Muscle Taurine and Clinical Blood Parameters in Healthy Males
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- University of Sao Paulo · Academic / Other
- Sex
- Male
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
Although β-alanine (BA) has been shown to be an effective ergogenic aid, little information exists on the safety of chronic supplementation despite potential concerns. The aim of this study was to investigate the effects of chronic BA supplementation on muscle taurine content, blood clinical markers and sensory side-effects during 24 weeks of BA supplementation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Beta-alanine | Beta-alanine in sustained-release tablets to increase muscle carnosine content |
| DIETARY_SUPPLEMENT | Placebo | Maltodextrin is used as a placebo as it does not lead to any increases in muscle carnosine |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2015-12-15
- Completion
- 2017-12-15
- First posted
- 2018-08-31
- Last updated
- 2018-08-31
Source: ClinicalTrials.gov record NCT03655041. Inclusion in this directory is not an endorsement.